16 Einträge gefunden

1. Immune-related Gene Expression Predicts Response to Neoadjuvant Chemotherapy but not Additional Benefit from PD-L1 Inhibition in Women with Early Triple-negative Breast Cancer

   1. Sinn, Bruno V
   2. Loibl, Sibylle
   3. Hanusch, Claus A
   4. Zahm, Dirk-Michael
   5. Sinn, Hans-Peter
   6. Untch, Michael
   7. Weber, Karsten

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
2. AGO Algorithms for the Treatment of Breast Cancer: Update 2021

   1. Schneeweiss, Andreas
   2. Fasching, Peter A
   3. Fehm, Tanja
   4. Gerber, Bernd
   5. Jackisch, Christian
   6. Loibl, Sibylle
   7. Schmidt, Marcus

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
3. Association of Germline Variant Status With Therapy Response in High-risk Early-Stage Breast Cancer: A Secondary Analysis of the GeparOcto Randomized Clinical Trial

   1. Pohl-Rescigno, Esther
   2. Hauke, Jan
   3. Loibl, Sibylle
   4. Möbus, Volker
   5. Denkert, Carsten
   6. Fasching, Peter A
   7. Kayali, Mohamad

   2020 - Forschungsinformationssystem des UKE
4. Androgen receptor expression and response to chemotherapy in breast cancer patients treated in the neoadjuvant TECHNO and PREPARE trial

   1. Witzel, Isabell
   2. Loibl, Sibylle
   3. Wirtz, Ralph
   4. Fasching, Peter A
   5. Denkert, Carsten
   6. Weber, Karsten
   7. Lück, Hans-Joachim

   2019 - Forschungsinformationssystem des UKE
5. Risk Assessment after Neoadjuvant Chemotherapy in Luminal Breast Cancer Using a Clinicomolecular Predictor

   1. Loibl, Sibylle
   2. Weber, Karsten
   3. Huober, Jens
   4. Krappmann, Kristin
   5. Marmé, Frederik
   6. Schem, Christian
   7. Engels, Knut

   2018 - Forschungsinformationssystem des UKE
6. Prognostic impact of circulating tumor cells for breast cancer patients treated in the neoadjuvant "Geparquattro" trial

   1. Riethdorf, Sabine
   2. Müller, Volkmar
   3. Loibl, Sibylle
   4. Nekljudova, Valentina
   5. Weber, Karsten E
   6. Huober, Jens
   7. Fehm, Tanja

   2017 - Forschungsinformationssystem des UKE
7. Germline Mutation Status, Pathological Complete Response, and Disease-Free Survival in Triple-Negative Breast Cancer Secondary Analysis of the GeparSixto Randomized Clinical Trial

   1. Hahnen, Eric
   2. Lederer, Bianca
   3. Hauke, Jan
   4. Loibl, Sibylle
   5. Kröber, Sandra
   6. Schneeweiss, Andreas
   7. Denkert, Carsten

   2017 - Forschungsinformationssystem des UKE
8. Changes in serum levels of miR-21, miR-210, and miR-373 in HER2-positive breast cancer patients undergoing neoadjuvant therapy: a translational research project within the Geparquinto trial

   1. Müller, Volkmar
   2. Gade, Stephan
   3. Steinbach, Bettina
   4. Loibl, Sibylle
   5. von Minckwitz, Gunter
   6. Untch, Michael
   7. Schwedler, Kathrin

   2014 - Forschungsinformationssystem des UKE
9. Ki67 measured after neoadjuvant chemotherapy for primary breast cancer

   1. von Minckwitz, Gunter
   2. Schmitt, Wolfgang D
   3. Loibl, Sibylle
   4. Müller, Berit M
   5. Blohmer, Jens U
   6. Sinn, Bruno V
   7. Eidtmann, Holger

   2013 - Forschungsinformationssystem des UKE
10. Treatment of breast cancer during pregnancy: an observational study.

    1. Loibl, Sibylle
    2. Han, Sileny N
    3. von Minckwitz, Gunter
    4. Bontenbal, Marijke
    5. Ring, Alistair
    6. Giermek, Jerzy
    7. Fehm, Tanja

    2012 - Forschungsinformationssystem des UKE
11. Impact of treatment characteristics on response of different breast cancer phenotypes: pooled analysis of the German neo-adjuvant chemotherapy trials.

    1. von Minckwitz, Gunter
    2. Untch, Michael
    3. Nüesch, Eveline
    4. Loibl, Sibylle
    5. Kaufmann, Manfred
    6. Kümmel, Sherko
    7. Fasching, Peter A

    2011 - Forschungsinformationssystem des UKE
12. Comparison of pegfilgrastim on day 2 vs. day 4 as primary prophylaxis of intense dose-dense chemotherapy in patients with node-positive primary breast cancer within the prospective, multi-center GAIN study: (GBG 33).

    1. Loibl, Sibylle
    2. Müller, Volkmar
    3. von Minckwitz, Gunter
    4. Conrad, Bettina
    5. Koehne, Claus-Henning
    6. Kremers, Stephan
    7. Forstbauer, Helmut

    2011 - Forschungsinformationssystem des UKE
13. Detection and HER2 expression of circulating tumor cells: prospective monitoring in breast cancer patients treated in the neoadjuvant GeparQuattro trial.

    1. Riethdorf, Sabine
    2. Müller, Volkmar
    3. Zhang, Liling
    4. Rau, Thomas
    5. Loibl, Sibylle
    6. Komor, Martina
    7. Roller, Marc

    2010 - Forschungsinformationssystem des UKE
14. Monitoring serum HER2 levels during neoadjuvant trastuzumab treatment within the GeparQuattro trial.

    1. Witzel, Isabell
    2. Loibl, Sibylle
    3. von Minckwitz, Gunter
    4. Mundhenke, Christoph
    5. Huober, Jens
    6. Hanusch, Claus
    7. Henschen, Stephan

    2010 - Forschungsinformationssystem des UKE
15. Downregulation of human polo-like kinase activity by antisense oligonucleotides induces growth inhibition in cancer cells.

    1. Spänkuch-Schmitt, Birgit
    2. Wolf, Georg
    3. Solbach, Christine
    4. Loibl, Sibylle
    5. Knecht, Rainald
    6. Stegmüller, Manfred
    7. von Minckwitz, Gunter

    2002 - Forschungsinformationssystem des UKE
16. Anti-epidermal growth factor receptor-antibody therapy for treatment of breast cancer.

    1. Solbach, Christine
    2. Roller, Marc
    3. Ahr, Andre
    4. Loibl, Sibylle
    5. Nicoletti, Maria
    6. Stegmueller, Manfred
    7. Kreysch, Hans-Georg

    2002 - Forschungsinformationssystem des UKE